SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-127431
Filing Date
2017-04-18
Accepted
2017-04-18 16:37:02
Documents
3
Period of Report
2017-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d293927d8k.htm 8-K 13226
2 EX-99.1 d293927dex991.htm EX-99.1 10569
3 GRAPHIC g293927g44c41.jpg GRAPHIC 3437
  Complete submission text file 0001193125-17-127431.txt   29915
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 17767350
SIC: 2834 Pharmaceutical Preparations